Obstacles encountered in designing antiepileptic drug trials
French, J.A.
Epilepsy Research. Suppl 10: 81-89
1993
ISSN/ISBN: 0922-9833 PMID: 8251107 Document Number: 413435
Document emailed within 1 workday
Related Documents
Goldsmith, C.H. 1991: Challenges in designing antirheumatic drug trials Journal of Rheumatology 18(11): 1643-1644Mil'chakova, L.E.; Gekht, A.B. 2010: Efficacy and safety of a new antiepileptic drug lacosamide in patients with focal epilepsy: data of double-blind placebo controlled trials Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(3 Suppl 2: 39-43
Shorvon, S.D.; Tallis, R.C.; Wallace, H.K. 2002: Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice Journal of Neurology Neurosurgery and Psychiatry 72(1): 114-115
Hamada, C. 2015: Statistical Viewpoints on Designing Investigator Initiated Clinical Trials Nihon Geka Gakkai Zasshi 116(3): 176-180
Dimick, C. 2008: In search of quality quality initiatives. High interest, high obstacles in designing quality improvement programs Journal of Ahima 79(8): 38-41
Kelly, J.A.; Spielberg, F.; McAuliffe, T.L. 2008: Defining, designing, implementing, and evaluating phase 4 HIV prevention effectiveness trials for vulnerable populations Journal of Acquired Immune Deficiency Syndromes 47 Suppl. 1: S28-S33
Anctil, H. 2001: Soutien à domicile: lever les obstacles au développement - Support at home: overcoming the obstacles about development Gerontophile (Sainte-Foy) 23(1): 23-26
Bellamy, N.; Carette, S.; Ford, P.M.; Kean, W.F.; le Riche, N.G.; Lussier, A.; Wells, G.A.; Campbell, J. 1992: Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise Journal of Rheumatology 19(3): 451-457
Bloom, N.D. 2005: Les villes nouvelles ne sont pas des banlieues : Les obstacles à la planification des cités-jardins américaines - New towns are not suburbs obstacles to planning us garden cities Annales de la Recherche Urbaine (Paris) (98): 167-171
Bruni, J.; Wilder, B.J. 1979: Antiepileptic drug monitoring Journal of the Florida Medical Association 66(7): 697-699
Yerby, M.S.; Friel, P.N.; McCormick, K. 1992: Antiepileptic drug disposition during pregnancy Neurology 42(4 Suppl 5: 12-16
2011: Antiepileptic drug withdrawal in children Prescrire International 20(120): 245
Bruppacher, R.; Gelzer, J. 1991: Identifying, evaluating and quantifying adverse drug reactions in children: opportunities and obstacles for the manufacturer Bratislavske Lekarske Listy 92(11): 549-553
Pennell, P.B. 2003: Antiepileptic drug pharmacokinetics during pregnancy and lactation Neurology 61(6 Suppl 2): S35-S42
Eliasson, M.; Bergqvist, D. 2001: Research results should be freely accessible!-- Case reports demonstrate obstacles to contact with drug industry Lakartidningen 98(37): 3913-3916
Johnson, M.; Lajiness, M.; Maggiora, G. 1989: Molecular similarity: a basis for designing drug screening programs Progress in Clinical and Biological Research 291: 167-171
Bodonaik, N.C.; Chen, W.N. 1986: Serogroup frequency and drug sensitivity of Shigella strains encountered at the University Hospital of the West Indies West Indian Medical Journal 35(3): 194-196
Svatý, J. 1979: Valproate (dipropyl acetate)--a new-series antiepileptic drug Ceskoslovenska Pediatrie 34(5): 312-313
López-Terradas Covisa, J.M. 2003: Criteria for beginning and stopping antiepileptic drug therapy Revista de Neurologia 37(3): 287-292
Kankirawatana, P. 1999: Salivary antiepileptic drug levels in Thai children Journal of the Medical Association of Thailand 82(1): 80-88